NCT02513641View on ClinicalTrials.gov

Effect of 2-Week Nightly Moderate Hypoxia on Glucose Tolerance in Individuals With Type 2 Diabetes

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

April 30, 2018

Study Completion Date

September 30, 2020

Conditions
Type 2 Diabetes
Interventions
DEVICE

Hypoxico Altitude Training Systems

Participants will sleep in a tent (which will fit his/her personal mattress) simulating an altitude of \~2,400 meters for 7-12 hours each night for a period of 14 days. Baseline testing measures will include a oral glucose tolerance test (OGTT) and body composition (iDXA). Post-treatment testing measures will include OGTT only.

Trial Locations (2)

70808

Pennington Biomedical Research Center, Baton Rouge

70809

Pennington Biomedical Research Center, Baton Rouge

All Listed Sponsors
lead

Pennington Biomedical Research Center

OTHER

NCT02513641 - Effect of 2-Week Nightly Moderate Hypoxia on Glucose Tolerance in Individuals With Type 2 Diabetes | Biotech Hunter | Biotech Hunter